Orgenesis Inc. (ORGS)
OTCMKTS
· Delayed Price · Currency is USD
0.580
+0.470 (427.27%)
Apr 24, 2026, 4:00 PM EST
Orgenesis Employees
Orgenesis had 77 employees as of December 31, 2024. The number of employees decreased by 69 or -47.26% compared to the previous year.
Employees
77
Change (1Y)
-69
Growth (1Y)
-47.26%
Revenue / Employee
$13,442
Profits / Employee
-$625,519
Market Cap
7.06M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Mosaic ImmunoEngineering | 8 |
| ZIVO Bioscience | 7 |
| AccuStem Sciences | 4 |
| Synlogic | 1 |
| Galera Therapeutics | 3 |
| NKGen Biotech | 26 |
Orgenesis News
- 4 weeks ago - Okogen Acquires Ranpirnase Assets and Intellectual Property Portfolio - Newsfile Corp
- 1 year ago - Orgenesis Inc. Announces Acquisition of Certain Neurocords LLC Assets, Strengthening its Regenerative Medicine Portfolio with Spinal Cord Injury Therapies - Accesswire
- 1 year ago - Orgenesis Secures Up to $5 Million Equity Investment from Williamsburg Venture Holdings - Accesswire
- 1 year ago - Orgenesis Announces Positive Results From a Real-World Study of ORG-101 CAR-T Therapy in Patients with CD19+ Acute Lymphoblastic Leukemia - GlobeNewsWire
- 1 year ago - Orgenesis Announces Strategic Partnership with Harley Street Healthcare Group to Launch a State-of-the-Art Longevity & Wellness Initiative Globally - GlobeNewsWire
- 2 years ago - Orgenesis Provides Business Update for the First Quarter of 2024 - GlobeNewsWire
- 2 years ago - Orgenesis Provides Year End Business Update - GlobeNewsWire
- 2 years ago - Germfree and Orgenesis Announce Asset Purchase and Strategic Partnership Intended to Revolutionize Cell and Gene Therapy Through Decentralized Production and Global Accessibility - GlobeNewsWire